Osteopenia and osteoporosis after allogeneic hematopoietic stem cell transplantation, features of bone mineral turnover pathology in children
- Authors: Skvortsova Y.V.1, Balashov D.N.1, Maschan A.A.1
-
Affiliations:
- Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology
- Issue: Vol 16, No 4 (2017)
- Pages: 98-106
- Section: Статьи
- Submitted: 09.08.2018
- Published: 09.11.2017
- URL: https://hemoncim.com/jour/article/view/15
- DOI: https://doi.org/10.24287/1726-1708-2017-16-4-98-106
- ID: 15
Cite item
Full Text
Abstract
Among the numerous late effects of allogeneic hematopoietic stem cell transplantation (HSCT) the bone turnover pathology remains one of the frequent. Osteopenia and osteoporosis are multifactorial, progressive and long-term disturbances. They can lead to bone fractures and disability and significantly reduce the quality of life. In-time diagnostic of osteopenia and osteoporosis, appropriate and individualized therapeutic approach allow to improve the prognosis of patients. This article describes pathogenesis, diagnostic and recent treatment options of bone mineral pathology after allogeneic HSCT. Pecularities of these complications in children population are reviewed separately.
About the authors
Y. V. Skvortsova
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology
Author for correspondence.
Email: yuscvo@mail.ru
ORCID iD: 0000-0002-0566-053X
MD, hematologist of HSCT Department #2
Russia 117997, Moscow, Samory Mashela st., 1
+7 (915) 069-3743
D. N. Balashov
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, ImmunologyRussian Federation
A. A. Maschan
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology
ORCID iD: 0000-0002-0016-6698
Russian Federation
References
Supplementary files
